VIDEO

FindCenter AddIcon

Psychedelic Therapy with Roland Griffiths, PhD

By Roland Griffiths — 2020

Psilocybin, LSD and other psychedelic drugs were once considered promising treatments for depression, anxiety and other mental health ailments. Now, after a decades-long lull, researchers are once again looking into the therapeutic potential of these drugs. See more...

44:55 min

Psilocybin Therapy May Work as Well as Common Antidepressant

The first randomized controlled trial to compare the illicit psychedelic psilocybin with a conventional selective serotonin reuptake inhibitor (SSRI) antidepressant found that the former improved symptoms of depression just as well on an established metric—and had fewer side effects.

Article
Zoe Cormier
2021
FindCenter AddIcon

Study Finds Ketamine Can Help Patients Manage Depression and PTSD

Through this treatment plan, the patient was able to “reconceptualize her trauma” and “was able to move through difficult memories and emotions rather than letting them consume her,” explained U of O associate professor, Monnica Williams.

Article
Hannah Sabourin
2021
FindCenter AddIcon

Introducing Ayahuasca

Amazonian healing traditions collide with Western medical sensibilities.

Article
Zoe Jahn, Monnica T. Williams
2019
FindCenter AddIcon

Are Psychedelics the Answer to Depression and Addiction?

A new generation of research into psilocybin could change how we treat numerous mental health conditions.

Article
Johann Hari
2018
FindCenter AddIcon

Scientists Gave Depressed Patients Psilocybin in a First for Psychedelic Therapy

In a recent UK trial, 12 patients with major depression took a pill quite different to commonly prescribed antidepressants: 25mg of psilocybin, the psychedelic compound found in magic mushrooms.

Article
Victoria Turk
2016
FindCenter AddIcon

We Can No Longer Ignore the Potential of Psychedelic Drugs to Treat Depression

At Imperial College we’ve been comparing psilocybin to conventional antidepressants—and the results are likely to be game-changing.

Article
Robin Carhart-Harris
2020
FindCenter AddIcon

How to Change Your Mind: What the New Science of Psychedelics Teaches Us about Consciousness, Dying, Addiction, Depression, and Transcendence

When Michael Pollan set out to research how LSD and psilocybin (the active ingredient in magic mushrooms) are being used to provide relief to people suffering from difficult-to-treat conditions such as depression, addiction, and anxiety, he did not intend to write what is undoubtedly his most...

Book
Michael Pollan
2019
FindCenter AddIcon

Ketamine Therapy Is Going Mainstream. Are We Ready?

The mind-altering drug has been shown to help people suffering from anxiety and depression. But how it helps, who it will serve, and who will profit are open questions.

Article
Emily Witt
2021
FindCenter AddIcon

I Took Ketamine for My Depression. Things Got Pretty Weird.

My first encounter with ketamine did not go well.

Article
Vanessa Barbara
2021
FindCenter AddIcon

One Dose of ‘Magic Mushroom’ Drug Reduces Anxiety and Depression in Cancer Patients, Study Says

A single dose of psilocybin, a compound found in “magic mushrooms,” provides long-term relief of anxiety and depression in cancer patients, a new study finds.

Article
Meera Senthilingam
2020
FindCenter AddIcon

EXPLORE TOPIC

Psychedelic Research